KB Home (KBH) swung to profit in the first quarter of 2019 from a loss last year, helped by lower income tax expense. The bottom line exceeded analysts’ expectations while the top line missed consensus estimates. A decline in homebuilding revenue hurt the top line. Following this, the stock inched up over 1% in the after-market session.
Net income for the quarter was $30 million or $0.31 per share compared to a loss of $71.3 million or $0.82 per share in the previous year quarter. However, revenue fell 7% to $811.5 million due to lower homebuilding revenue.
The company delivered a total of 2,152 homes during the quarter, down 3.2% compared to last year. The average selling price declined 5% to $370,900 due primarily to a shift in geographic mix of homes delivered and a lower average selling price in the company’s West Coast region.
Net orders for the first quarter fell 4% to 2,675, and net order value dropped 13% to $1.02 billion. The number of homes in ending backlog decreased 6.9% to 4,631 and ending backlog value plunged 16% to $1.66 billion. The decrease in backlog value reflects fewer homes in backlog and the lower average selling price of those homes due to a shift in geographic mix.
The company had total liquidity of $978.5 billion as of February 28, 2019, including cash and cash equivalents of $511.7 million. Inventories increased by 3% to $3.68 billion. Stockholders’ equity increased by 2% to $2.13 billion from November 30, 2018.
Shares of KB Home ended Wednesday’s regular session up 0.88% at $24.08 on the NYSE. The stock has fallen over 15% in the past year while it has risen over 24% in the past three months.
Listen to on-demand earnings calls and hear how management responds to analysts’ questions
Most Popular
CVX Earnings: Chevron reports lower revenue and profit for Q1 2024
Energy exploration company Chevron Corporation (NYSE: CVX) announced first-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation was $5.50 billion or
ABBV Earnings: AbbVie reports lower adj. profit for Q1 2024; revenue edges up
Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and a modest rise in revenues. The company reported worldwide net
CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q1 2024 financial results
Colgate-Palmolive Company (NYSE: CL) reported first quarter 2024 earnings results today. Net sales increased 6.2% year-over-year to $5.06 billion. Organic sales increased 9.8%. Net income attributable to Colgate-Palmolive Company was